New York State Common Retirement Fund’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,314
Closed -$5K 3198
2025
Q1
$5K Hold
2,314
﹤0.01% 3119
2024
Q4
$14K Hold
2,314
﹤0.01% 3087
2024
Q3
$16K Hold
2,314
﹤0.01% 3065
2024
Q2
$13K Buy
2,314
+41
+2% +$230 ﹤0.01% 3230
2024
Q1
$16K Hold
2,273
﹤0.01% 3158
2023
Q4
$11K Sell
2,273
-24
-1% -$116 ﹤0.01% 3188
2023
Q3
$22K Buy
2,297
+22
+1% +$211 ﹤0.01% 3168
2023
Q2
$29K Buy
2,275
+69
+3% +$880 ﹤0.01% 3212
2023
Q1
$28K Buy
+2,206
New +$28K ﹤0.01% 3077